Blood 2017-08-31
Posttransplant feasibility study of nilotinib prophylaxis for high-risk Philadelphia chromosome positive leukemia.
Related Questions
New answer by Medical Oncologist at University of Washington (September 23, 2020)
While ABL kinase inhibitors (TKIs) are commonly recommended as maintenance post-transplant in Ph+ ALL, the data supporting this practice are relatively soft. Position statemen...